Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in C… (NCT01075789) | Clinical Trial Compass
TerminatedNot Applicable
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
Stopped: Failure to recruit
Australia13 participantsStarted 2010-05
Plain-language summary
Nasogastric tube insertion is one of the most common invasive procedures performed in children's hospitals, and has long been recognised as one of the most traumatic and painful. As a once off procedure, a nasogastric tube insertion is extremely distressing but the repeated procedures that many children endure as a necessary part of treatment for a chronic disease can be so traumatic that psychological damage may occur. There have been a limited number of studies carried out which have looked at methods to reduce the pain and trauma associated with this procedure, but most of these have been carried out in the adult population.
The investigators propose to carry out a research project in a paediatric setting to definitively investigate the use of local anaesthetic spray, in combination with local anaesthetic gel, to numb the nasal passages and the back of the throat, with the aim of reducing or removing the unpleasant sensation of the nasogastric tube placement. If the study shows a benefit from the use of local anaesthetics, it would be an inexpensive and easily incorporated intervention that could be inserted into the routine procedure for nasogastric tube insertion.
Who can participate
Age range6 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Signed informed consent from parent of guardian
✓. Signed assent from subject
✓. Subject must have insertion of a nasogastric tube ordered as part of his/her current treatment
✓. Must be 6 years of age or older
✓. Must be able to complete visual analogue scale (VAS)
Exclusion criteria
✕. Congenital abnormalities of the naso/oropharyngeal area
✕. Any surgical alterations in the naso/oropharyngeal area
✕. Mucositis
✕. Known history of hypersensitivity to xylocaine or other local anaesthetics
✕. Known history of hypersensitivity to other components of the xylocaine solutions such as methyl or propyl hydroxybenzoate, ethanol, polyethylene glycol 400, banana flavour PHL-131980, menthol, saccharin
What they're measuring
1
Reduction in mean visual analogue scores (VAS) in study arm
Timeframe: 10 minutes following nasogastric tube intubation